Timeline

Jamie Sugrue
Post-doc
14 Sep 2025
publication

Dazukibart for the treatment of severe TIF1γ-positive juvenile dermatomyositis.

Read more
01 Sep 2025
publication

Altered DNA methylation of the ABO gene is associated with differential plasma levels of von willebrand factor and E‐selectin

Read more
28 Mar 2025
publication

Steroid hormone levels vary with sex, aging, lifestyle, and genetics

Read more
01 Sep 2024
publication

Immune system adaptation during gender-affirming testosterone treatment.

Read more
07 Mar 2024
publication

Systems vaccinology studies – achievements and future potential.

Read more
01 Feb 2023
publication

Innate antiviral immunity and immunometabolism in hepatocytes.

Read more
25 Nov 2022
publication

Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity.

Read more
15 Nov 2022
publication

Enhanced TLR3 responsiveness in hepatitis C virus resistant women from the Irish anti-D cohort.

Read more
28 Jun 2022
publication

Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation.

Read more
15 Apr 2022
publication

Rhesus negative males have an enhanced IFNγ-mediated immune response to influenza A virus.

Read more
01 Apr 2022
publication

Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression.

Read more
28 Feb 2022
publication

Uncovering Resistance to Hepatitis C Virus Infection: Scientific Contributions and Unanswered Questions in the Irish Anti-D Cohort.

Read more
01 Jan 2021
publication

Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature.

Read more
02 Jul 2020
team

Translational Immunology

Read more
01 Jan 2020
publication

Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection.

Read more
01 Apr 2019
publication

How I was almost mistaken for a chocolatier.

Read more
11 Mar 2019
publication

The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages.

Read more